These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Multiple sclerosis, the therapeutic arsenal of today and tomorrow]. Zéphir H Soins; 2009 Nov; (740):39-41. PubMed ID: 20014532 [No Abstract] [Full Text] [Related]
10. A new treatment era in multiple sclerosis: clinical applications of new concepts. Edan G; Leray E J Neurol Sci; 2011 Jul; 306(1-2):170-2. PubMed ID: 20951999 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies in the treatment of multiple sclerosis. Di Pauli F; Berger T; Reindl M Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782 [TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies and their targets in the treatment of multiple sclerosis]. Chan A Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S10-1. PubMed ID: 24242028 [No Abstract] [Full Text] [Related]
13. Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench. Coles A; Deans J; Compston A Clin Neurol Neurosurg; 2004 Jun; 106(3):270-4. PubMed ID: 15177782 [No Abstract] [Full Text] [Related]
14. Treating multiple sclerosis with monoclonal antibodies. Buttmann M; Rieckmann P Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973 [TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab versus interferon beta-1a: implications for pathology and trial design. McFarland HF Lancet Neurol; 2009 Jan; 8(1):26-8. PubMed ID: 19081510 [No Abstract] [Full Text] [Related]
17. Multiple sclerosis: advances in understanding pathogenesis and emergence of oral treatment options. Bermel RA; Cohen JA Lancet Neurol; 2011 Jan; 10(1):4-5. PubMed ID: 21163434 [No Abstract] [Full Text] [Related]
18. Clinical trials with CAMPATH-I and other monoclonal antibodies. Hale G; Phillips JM Biochem Soc Trans; 1995 Nov; 23(4):1057-63. PubMed ID: 8654681 [No Abstract] [Full Text] [Related]
19. Specific immune intervention with monoclonal antibodies for the treatment of multiple sclerosis. Trebst C; Voss E; Skripuletz T; Stangel M Curr Med Chem; 2010; 17(7):640-50. PubMed ID: 20088763 [TBL] [Abstract][Full Text] [Related]
20. [Development of new therapies for multiple sclerosis]. Holmøy T; Celius EG Tidsskr Nor Laegeforen; 2011 May; 131(8):832-6. PubMed ID: 21556088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]